DRUG

DRUG EV to Operating Cash Flow

-17.12×TTM

Retrieved:

DRUG FY EV/OCF
DRUG FY EV/OCF155.96×-1457.52×
2019-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

DRUG ev to operating cash flow history

Enterprise value to operating cash flow ratio. The available annual fiscal periods series contains 7 observations from Sep 30, 2019 to Sep 30, 2025.

Bright Minds Biosciences Inc EV to Operating Cash Flow — Annual fiscal periods
Period endingEV to Operating Cash Flow
-57.257×
-0.3972×
-0.1881×
-0.6999×
-8.384×
-187.071×
-1,301.3811×

Compare ev to operating cash flow

All DRUG financial metrics · DRUG stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.